Trilogy Tactical Medicine offering TECC Nationwide
Trilogy's Tactical Medicine Division has launched a nationwide TECC training program for Fire and EMS agencies. Building on the success of Trilogy's Law Enforcement Street Survival &Tactical Medicine Instructor program, providing the NAEMT TECC course to coincide with the law enforcement training is the next logical progression. It is Trilogy's mission to reach as many street personnel as possible to provide this critical training. It reinforces the Hartford Consensus and prepares EMS personnel to work efficiently and safely in an active shooter or similar situation. Training with tourniquets and hemostatic agents is no longer a luxury but a necessity. Law enforcement officers across the United States are learning the skills necessary to aid in bridging the gap between point of injury and arrival of dedicated EMS assets. It is imperative that those arrive assets have the same level of training and knowledge as their law enforcement counterparts. This is becoming a team effort and will ultimately save many more lives. All tactical medicine courses are conducted with TOMM, Tactical Operations Medical Mannequin. Developed and manufactured by ITTS it was designed by decorated Air Force PJ Keary Miller to endure the tactics and training of pararescue personnel. TOMM will breathe, bleed, and talk while rescuers are able to perform surgical airway, needle decompression, intravenous therapy, tourniquets, and wound packing. It is versatile and a game changer for providing ta...
PMID: 31108520 [PubMed - in process]
Across Canada, private clinics charge thousands of dollars for injections and IV therapies using what they claim are stem cells. This week, Health Canada ruled that those cell therapies are drugs that must be approved. But so far, the agency has not ordered clinics to stop doing the procedures.
Arrow PICC powered by Arrow VPS Precision Stylet Product Code:CDC-45052-VPS2 Product Usage: The Arrow Pressure Injectable PICC is indicated for short-term or longterm peripheral access to the central venous system for intravenous therapy, blood sampling, infusion, pressure injection of contrast media and allows for central venous pressure monitoring. The maximum pressure of pressure injector equipment used with the pressure injectable PICC may not exceed 300 psi.
ConclusionsOnly 2% of patients were switched from IV to oral antibiotics in our study while almost one-third were ES eligible. Additionally, one-third of hospitalized patients with MRSA cSSTI were ED eligible indicating opportunity for reducing IV therapy and days of hospital stay. These results provide insight into possible benefits of implementation of ES/ED protocols in Brazil.
CONCLUSIONS: Only 2% of patients were switched from IV to oral antibiotics in our study while almost one-third were ES eligible. Additionally, one-third of hospitalized patients with MRSA cSSTI were ED eligible indicating opportunity for reducing IV therapy and days of hospital stay. These results provide insight into possible benefits of implementation of ES/ED protocols in Brazil. PMID: 31078574 [PubMed - as supplied by publisher]
This research provides good evidence that bone and joint infections can be treated with predominantly oral regimens. This could have several benefits, not least the greater freedom afforded to patients and reduced costs.The importance of taking the medication and potential treatment side effects need to be explained so that patients can seek medical support to modify the treatment when necessary. Also, staff perceptions surrounding the effectiveness of oral antibiotics for this indication also need to be addressed to enable a shift in practice.
CONCLUSION: These new recommendations, close to French practices, help clinicians to find the right time for referral of patients to transplantation centers. This is crucial for the prognosis of lung transplantation. PMID: 31006579 [PubMed - as supplied by publisher]
We present two cases of IE in children caused by uncommon pathogenic bacteria (Abiotrophia defectiva and Haemophilus parainfluenzae) successfully treated with oral third-generation cephalosporin - cefpodoxime proxetil after initial intravenous therapy. This paper provides observations on different therapeutic approach for IE in children as well as another potential use of cefpodoxime proxetil. PMID: 31007148 [PubMed - as supplied by publisher]
Abstract Andrew Barton and NIVAS board colleagues have produced evidence-based guidelines for health profesionals on how to avoid under-dosing in IV therapy. These guidelines, in association with NIVAS, are presented here. PMID: 31002556 [PubMed - in process]
CONCLUSION: Overall, the results showed that many patients place a high value on treatment benefits over other treatment attributes including serious or minor side effects, cost or route of administration. The variability in patient preferences highlights the need to individualize treatment choices in RA. PMID: 30988125 [PubMed - as supplied by publisher]